FDA Creates New Advisory Committee for Evaluation of Genetic Metabolic Disease Treatments

Today, the U.S. Food and Drug Administration announced it is creating a new advisory committee related to potential treatments for genetic metabolic diseases.

https://www.fda.gov/news-events/press-announcements/fda-creates-new-advisory-committee-evaluation-genetic-metabolic-disease-treatments

Related articles

View all the news and events
Conference

MENA Congress for Rare Diseases in Abu Dhabi

 From May 16, 2024 to May 19, 2024

This conference is a unique platform that brings all parties involved in rare diseases to one place to obtain the most updated knowledge, increase …